Sakamoto Takashi, Mukai Toshiki, Noguchi Tatsuki, Matsui Shimpei, Yamaguchi Tomohiro, Akiyoshi Takashi, Kawachi Hiroshi, Fukunaga Yosuke
Department of Gastroenterological Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto-Ku, Tokyo, 135-8550, Japan.
Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto-Ku, Tokyo, 135-8550, Japan.
Surg Today. 2025 Jan 31. doi: 10.1007/s00595-025-02999-y.
The pattern of lymph node metastasis and the appropriate extent of lymph node dissection in splenic flexure colon cancer remain unclear. This study aimed to describe the clinical characteristics, lymph node metastasis patterns, and oncological outcomes of patients with splenic flexure colon cancer.
The data of patients with splenic flexure cancer diagnosed with pathological stages I-III were extracted from a hospital database. Lymph nodes were mapped and numbered according to the guidelines of the Japanese Society for Cancer of the Colon and Rectum. Five-year disease-free survival (DFS) and overall survival (OS) rates were estimated using the Kaplan-Meier method.
Among 151 patients, 37.1% had lymph node metastasis. The proportion of lymph node metastasis were 30.1% at station 221, 5.1% at station 222, 2.8% at station 223, 19.8% at station 231, 2.7% at station 232, and 0% at station 253. Among the 59 patients with an accessory middle colic artery, 19 had lymph node metastasis only at stations 221 (14/47) and 231 (5/47). The 5-year estimated DFS rates were 100% for stage I, 94.4% (95% CI, 83.6-98.2) for stage II, and 79.9% (95% CI, 65.6-88.8) for stage III. Ten patients experienced distant recurrence: liver (n = 5), peritoneum (n = 2), para-aortic lymph node (n = 2), and lung metastasis (n = 1). No local recurrence was observed.
In splenic flexure colon cancer, lymph node dissection around the IMA route may be omitted. Similarly, dissection along the left branch of the middle colic artery or the left colic artery may be unnecessary in the presence of an accessory middle colic artery.
脾曲结肠癌的淋巴结转移模式及合适的淋巴结清扫范围仍不明确。本研究旨在描述脾曲结肠癌患者的临床特征、淋巴结转移模式及肿瘤学结局。
从医院数据库中提取病理分期为I - III期的脾曲癌患者数据。根据日本结直肠癌学会的指南对淋巴结进行定位和编号。采用Kaplan - Meier法估计5年无病生存率(DFS)和总生存率(OS)。
151例患者中,37.1%有淋巴结转移。221组淋巴结转移比例为30.1%,222组为5.1%,223组为2.8%,231组为19.8%,232组为2.7%,253组为0%。在59例有副中结肠动脉的患者中,19例仅在221组(14/47)和231组(5/47)有淋巴结转移。I期患者的5年估计DFS率为100%,II期为94.4%(95%CI,83.6 - 98.2),III期为79.9%(95%CI,65.6 - 88.8)。10例患者发生远处复发:肝转移(n = 5)、腹膜转移(n = 2)、腹主动脉旁淋巴结转移(n = 2)和肺转移(n = 1)。未观察到局部复发。
在脾曲结肠癌中,可省略沿IMA途径的淋巴结清扫。同样,在存在副中结肠动脉的情况下,沿中结肠动脉左支或左结肠动脉的清扫可能也无必要。